Ir directamente a la navegación principal Ir directamente a la búsqueda Ir directamente al contenido principal

Smoking and Smoking Cessation Among Persons with Tobacco- and Non-tobacco-Associated Cancers

  • M. Shayne Gallaway
  • , Bin Huang
  • , Quan Chen
  • , Thomas C. Tucker
  • , Jaclyn K. McDowell
  • , Eric Durbin
  • , Sherri L. Stewart
  • , Eric Tai

Producción científica: Articlerevisión exhaustiva

32 Citas (Scopus)

Resumen

Purpose: To examine smoking and use of smoking cessation aids among tobacco-associated cancer (TAC) or non-tobacco-associated cancer (nTAC) survivors. Understanding when and if specific types of cessation resources are used can help with planning interventions to more effectively decrease smoking among all cancer survivors, but there is a lack of research on smoking cessation modalities used among cancer survivors. Methods: Kentucky Cancer Registry data on incident lung, colorectal, pancreatic, breast, ovarian, and prostate cancer cases diagnosed 2007–2011, were linked with health administrative claims data (Medicaid, Medicare, private insurers) to examine the prevalence of smoking and use of smoking cessation aids 1 year prior and 1 year following the cancer diagnosis. TACs included colorectal, pancreatic, and lung cancers; nTAC included breast, ovarian, and prostate cancers. Results: There were 10,033 TAC and 13,670 nTAC survivors. Smoking before diagnosis was significantly higher among TAC survivors (p < 0.0001). Among TAC survivors, smoking before diagnosis was significantly higher among persons who: were males (83%), aged 45–64 (83%), of unknown marital status (84%), had very low education (78%), had public insurance (89%), Medicaid (85%) or were uninsured (84%). Smoking cessation counseling and pharmacotherapy were more common among TAC than nTAC survivors (p < 0.01 and p = 0.05, respectively). Discussion: While smoking cessation counseling and pharmacotherapy were higher among TAC survivors, reducing smoking among all cancer survivors remains a priority, given cancer survivors are at increased risk for subsequent chronic diseases, including cancer. Tobacco cessation among all cancer survivors (not just those with TAC) can help improve prognosis, quality of life and reduce the risk of further disease. Health care providers can recommend for individual, group and telephone counseling and/or pharmacotherapy recommendations. These could also be included in survivorship care plans.

Idioma originalEnglish
Páginas (desde-hasta)552-560
Número de páginas9
PublicaciónJournal of Community Health
Volumen44
N.º3
DOI
EstadoPublished - jun 15 2019

Nota bibliográfica

Publisher Copyright:
© 2019, Springer Science+Business Media, LLC, part of Springer Nature.

Financiación

Funding Funds to support this work were received from the Centers for Disease Control and Prevention [National Center for Chronic Disease Prevention and Health Promotion (U48DP0085014-01 SIP = 14-017)], and Markey Cancer Center Support Grant [Division of Cancer Prevention, National Cancer Institute (NCI P30 CA177558)].

FinanciadoresNúmero del financiador
Markey Cancer Center
Centers for Disease Control and PreventionU48DP0085014-01 SIP = 14-017
Centers for Disease Control and Prevention
National Childhood Cancer Registry – National Cancer InstituteP30CA177558
National Childhood Cancer Registry – National Cancer Institute

    ODS de las Naciones Unidas

    Este resultado contribuye a los siguientes Objetivos de Desarrollo Sostenible

    1. Good health and well being
      Good health and well being

    ASJC Scopus subject areas

    • Health(social science)
    • Public Health, Environmental and Occupational Health

    Huella

    Profundice en los temas de investigación de 'Smoking and Smoking Cessation Among Persons with Tobacco- and Non-tobacco-Associated Cancers'. En conjunto forman una huella única.

    Citar esto